ARCHIVES

Clinical Trials Approved By NCI CTEP Last Month

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

Cancer Letter On Vacation

August 3, 1984

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993

Funding opportunities listed.

February 20, 2004

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005